Breakthrough T1D (formerly known as JDRF) is leading the way with Type One Diabetes (T1D) research. It’s the world’s largest nonprofit funder for T1D research. Breakthrough T1D is working to find a cure for this autoimmune disease that affects the pancreas’ ability to produce insulin.
For more information visit breakthrought1d.org
ACTT is featured on Breakthrough T1D’s website!
In honor of National Diabetes Awareness Month, ACTT was featured on Breakthrough T1D’s website! This article showcases what ACTT has done over the past 20 years, and includes an interview with Izzy Scheibel (Choreographer & Educational Director). This article was published November 2023. Read it below!
Izzy & JDRF in 2023
Izzy Scheibel, 7th year ACTT member & current leadership team member, is a participant of the 2023 JDRF Congress.
As stated on JDRF’s official site, “Every two years, more than 160 children with type 1 diabetes (T1D) between the ages of 4 – 17 gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. Government. The selected Delegates represent all 50 states and the District of Columbia, as well as JDRF’s five International Affiliates. As participants in JDRF Children’s Congress, Delegates have a unique and empowering opportunity to help Members of Congress understand what life with T1D is like, while forming lasting bonds with fellow youth who live with this autoimmune disease” (JDRF).
“About JDRF Children’s Congress.” JDRF Children’s Congress, cc.jdrf.org/about-jdrf-childrens-congress/.